Plain-English translation of NCT07121972 on ClinicalTrials.gov ↗ · Source last updated · Translation generated · How we translate trials
This study doesn't follow the usual testing phases — it may be an observational study or a different type of research.
This trial is testing whether supplemental breast MRI screening can catch breast cancer earlier in women who appear high-risk according to an artificial intelligence (AI) model called Mirai. You would have a regular mammogram first, and if the AI model identifies you as high-risk, you would receive an additional MRI scan. Researchers want to learn how well this extra MRI finds cancers that the standard mammogram might have missed.
Some women have dense breast tissue or other features that make it harder for standard mammograms to detect early cancer. This study aims to see whether adding an MRI scan can find more cancers at earlier, more treatable stages in women the AI model flags as high-risk.
You likely qualify if…
You likely don't qualify if…
After your screening mammogram, if the AI model identifies you as high-risk, you would be invited to participate. You would complete a supplemental breast MRI scan (a detailed imaging test) within 12 months of your mammogram. Before the MRI, researchers would also assess your breast cancer risk using a standard medical tool called the Tyrer-Cuzick model and collect information about your health history. The study tracks how many cancers the MRI detects and how accurate it is, with researchers following up on any findings.
AI-generated summary from trial data · Jun 12, 2026 · Not medical advice
United States